BacilliFinder: Revolutionizing Tuberculosis Detection with Computer Vision [0.03%]
BacilliFinder：用计算机视觉技术革新结核病检测
Nagaraju Y,Venkatesh,Rajani G et al.
Nagaraju Y et al.
Background: Pulmonary tuberculosis, caused by Mycobacterium, remains a global health concern despite being treatable, preventable, and curable. Diagnosis traditionally relies on X-rays and sputum smear samples. However, s...
Mutation analysis of the latency-associated gene Rv2660c in Mycobacterium tuberculosis clinical isolates from South Sulawesi, Indonesia: In-silico prediction of implications for antigenicity [0.03%]
印尼南苏拉威西临床分离的结核分枝杆菌潜伏相关基因Rv2660c突变分析及抗原性影响的预测研究
Sadiya Ramli,Nihayatul Karimah,Astutiati Nurhasanah et al.
Sadiya Ramli et al.
Background: The Rv2660c gene, associated with Mycobacterium tuberculosis (Mtb) latency and survival, is considered highly conserved. However, genetic variations may influence pathogenicity and drug resistance. This study ...
"Comparative study of gastric aspirate and bronchoalveolar lavage smear with CBNAAT examination for diagnosis of pulmonary tuberculosis in sputum smear negative suspected patients" [0.03%]
胃液与支气管肺泡灌洗液涂片及CBNAAT检查用于诊断痰涂片阴疑结核病患者的诊断价值比较研究
Abhi D Mukharya,Madhavi L Dhameliya,Jigna B Dave et al.
Abhi D Mukharya et al.
Introduction: Pulmonary tuberculosis (TB) continues to pose a significant global health challenge, particularly in low- and middle-income countries (LMICs), where the burden of the disease is highest. Despite advances in ...
Observational Study
The Indian journal of tuberculosis. 2025 Dec:72 Suppl 2:S56-S59. DOI:10.1016/j.ijtb.2025.04.002 2025
Trends in TB scores and efficiency of molecular diagnostic methods across key districts of Madhya Pradesh [0.03%]
印度中央邦重点地区TB评分和分子诊断方法效率的变化趋势
Manohar Bhatia,Vikas Sabharwal,Vikas Dwivedi et al.
Manohar Bhatia et al.
Background: Tuberculosis (TB) poses a significant public health challenge in India, contributing substantially to the global burden. Objectives: ...
The performance of A rpob gene mutation linked to A resistant to rifampicin mycobacterium tuberculosis isolate from an Indonesian referral hospital [0.03%]
来源于印度尼西亚一所转诊医院的对利福平具有抗性的结核杆菌分离菌株中与rpoB基因突变相关的耐药性表现
Deby Kusumaningrum,Ni Made Mertaniasih,Soedarsono Soedarsono
Deby Kusumaningrum
Introduction: Indonesia has the world's second-highest tuberculosis and is one of the 30 countries with an increased MDR/RR TB burden. Even though the number of people with tuberculosis is rising every year, several cases...
Comparing deep learning models for tuberculosis detection: A retrospective study of digital vs. analog chest radiographs [0.03%]
用于检测结核病的深度学习模型比较：数字与模拟胸部放射图像的回顾性研究
Subhankar Chattoraj,Bhargava Reddy,Manoj Tadepalli et al.
Subhankar Chattoraj et al.
Purpose: Chest X-ray (CXR) is an essential tool and one of the most prescribed imaging to detect pulmonary abnormalities, with a yearly estimate of over 2 billion imaging performed worldwide. However, the accurate and tim...
K K Chopra,V K Arora,Kaushal Kumar Dwivedi
K K Chopra
Effectiveness of FDA vital staining in follow UP of DR PTB patients on longer treatment regimen under NTEP [0.03%]
伏革染色法用于长程化疗晚期肺结核患者随访追踪效果分析
Aswathy S A,Anuj K Bhatnagar,M Hanif
Aswathy S A
Background: This high prevalent time of drug resistant tuberculosis need early finding of patients who are failing the longer treatment regimen, which can be done by using a simple method rather than using liquid culture ...
Observational Study
The Indian journal of tuberculosis. 2025 Dec:72 Suppl 2:S39-S42. DOI:10.1016/j.ijtb.2024.04.011 2025
Comparing diagnostic accuracy: Xpert MTB/RIF Ultra vs. Xpert MTB/RIF for diagnosis of pulmonary tuberculosis [0.03%]
Xpert MTB/RIF Ultra与Xpert MTB/RIF诊断肺结核的准确性比较研究
Sunil Sethi,Shelly Sharma,Sunil Kumar Dhatwalia et al.
Sunil Sethi et al.
Introduction: With the development of Xpert MTB/RIF (Xpert) and its latest version Xpert MTB/RIF Ultra (Ultra), diagnosis of tuberculosis has improved dramatically. Only few have compared the Ultra to Xpert, especially in...
A systematic review on cost-effectiveness of diagnostic methods and treatments for tuberculosis in India [0.03%]
印度结核病诊断和治疗的成本效益系统评价研究
Mohan Balakrishnan,R Varadharajan,G Gajendran
Mohan Balakrishnan
Objective: Cost-effectiveness of a treatment is based on additional health benefits offered and for a test it is determined by fast and improved diagnosing capacity. Evidence on cost-effectiveness can help in identifying ...